Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes Following a Moderately Hypofractionated Adjuvant Radiation (START B Type) Schedule for Breast Cancer in an Unscreened Non-Caucasian Population.
Chatterjee S, Arunsingh M, Agrawal S, Dabkara D, Mahata A, Arun I, Shrimali RK, Achari R, Mallick I, Ahmed R. Chatterjee S, et al. Among authors: mahata a. Clin Oncol (R Coll Radiol). 2016 Oct;28(10):e165-72. doi: 10.1016/j.clon.2016.05.008. Epub 2016 Jun 28. Clin Oncol (R Coll Radiol). 2016. PMID: 27369459
Resource requirements and reduction in cardiac mortality from deep inspiration breath hold (DIBH) radiation therapy for left sided breast cancer patients: A prospective service development analysis.
Chatterjee S, Chakraborty S, Moses A, Nallathambi C, Mahata A, Mandal S, Achari RB, Mallick I, Shrimali RK, Bhattacharyya T, Agrawal S, Ghosh J, Ahmed R. Chatterjee S, et al. Among authors: mahata a. Pract Radiat Oncol. 2018 Nov-Dec;8(6):382-387. doi: 10.1016/j.prro.2018.03.007. Epub 2018 Mar 21. Pract Radiat Oncol. 2018. PMID: 29699893
Development and validation of a decision support tool to select IMRT as radiotherapy treatment planning modality for patients with locoregionally advanced non-small cell lung cancers (NSCLC).
Shrimali RK, Chakraborty S, Bhattacharyya T, Mallick I, Achari RB, Prasath S, Arun B, Mahata A, Vidhya Shree M, Vishnupriya E, Chatterjee S. Shrimali RK, et al. Among authors: mahata a. Br J Radiol. 2019 Feb;92(1094):20180431. doi: 10.1259/bjr.20180431. Epub 2018 Nov 9. Br J Radiol. 2019. PMID: 30387364 Free PMC article.
Radical radiotherapy or chemoradiotherapy for inoperable, locally advanced, non-small cell lung cancer: Analysis of patient profile, treatment approaches, and outcomes for 213 patients at a tertiary cancer center.
Shrimali RK, Nallathambi C, Saha A, Das A, Prasath S, Mahata A, Arun B, Mallick I, Achari R, Dabkara D, Thambudorai R, Chatterjee S. Shrimali RK, et al. Among authors: mahata a. Indian J Cancer. 2018 Apr-Jun;55(2):125-133. doi: 10.4103/ijc.IJC_469_17. Indian J Cancer. 2018. PMID: 30604722 Free article.
Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial.
Chatterjee S, Chakraborty S; HYPORT Adjuvant Author Group. Chatterjee S, et al. Trials. 2020 Sep 30;21(1):819. doi: 10.1186/s13063-020-04751-y. Trials. 2020. PMID: 32998747 Free PMC article.
66 results